ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1813

Accuracy of Veterans Affairs Database for Gout-Related Health Care Utilization

Jasvinder A. Singh, Department of Medicine, University of Alabama, Tuscaloosa, AL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Rheumatic Disease Pharmacoepidemiology

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Gout outcome studies have used administrative and claims databases. It is unknown whether administrative-derived data are accurate for gout-related utilization.  The goal of the study was to assess the accuracy of Veterans Affairs (VA) administrative and clinical claims databases for gout-related health care utilization.

Methods:

This retrospective study utilized the VA administrative and clinical claims databases for the fiscal year 2006.  A cohort consisting of randomly mixed sample of two types of visits was identified that included visits with gout as primary or secondary diagnosis versus other diagnoses.  An experienced senior epidemiologist (JS) blinded to the database information related to the visit performed review of electronic medical records (EMR).  The gold standard was medical record documentation of gout or gout-related terms (gouty arthritis, tophaceous gout, acute gout, chronic gout, podagra, urate renal stones) in the chief complaint, history of present illness or assessment and plan for the visit.  This indicated that gout was the main reason or one of the main reasons for the visit. We assessed the accuracy of database-derived gout-related utilization by calculating sensitivity, specificity, and positive and negative predictive values (PPV and NPV). 

Results:

Of the 108 potential visits, 85 visits to a health care provider (in 85 patients: 84 men, 1 woman with mean age of 63 years) in one of the three settings (outpatient, inpatient or urgent care/emergency room), and retrievable data from medical records, constituted the analyzed dataset.  According to the gold standard of chart documentation, 21 visits were related to gout and 64 were not.  Administrative claims for visits related to gout were accurate with excellent PPV of 86%, sensitivity of 86%, specificity of 95% and NPV of 95%.  There were three visits coded as gout-related visit in databases that did not have medical record documentation related to gout: one visit each to discuss blood pressure medication, for regular follow-up of multiple medical problems, and for increased blood sugar.  Three visits coded as not related to gout in administrative databases were related to gout based on medical record documentation: one patient each with continuing acute gout flare, a new diagnosis with documentation of urate crystals in knee joint fluid, and chronic gout stable on allopurinol. 

Conclusion:

VA databases can be used to identify gout-related visits with good accuracy.  This finding supports the use of VA databases for studies of health services outcomes to identify gout-related utilization.  It remains to be seen if findings are generalizable to other clinical and/or claims databases.


Disclosure:

J. A. Singh,

research and travel grants from Takeda, Savient, Wyeth and Amgen,

2,

speaker honoraria from Abbott,

9,

Consultant fees from URL pharmaceuticals, Savient, Takeda, Ardea, Allergan and Novartis.,

5;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/accuracy-of-veterans-affairs-database-for-gout-related-health-care-utilization/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology